23 pending office actions • 18 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18622971 | Pharmaceutical Composition and Method for Treating or Preventing Candidiasis | Fempharma, LLC | YU, HONG | 1614 | Non-Final OA | Mar 31, 2024 |
| 18287848 | CEMENTITIOUS AND WATER-BASED EPOXY 3D PRINTING MORTAR AND METHODS FOR MAKING THE SAME | Unknown | WEISS, PAMELA HL | 1732 | Non-Final OA | Oct 20, 2023 |
| 18555079 | ENGINEERED HLA MOLECULES USEFUL FOR T CELL AND NK CELL ACTIVATION AND EXPANSION | Memorial Sloan Kettering Cancer Center | STAVROU, CONSTANTINA E | 1632 | Non-Final OA | Oct 12, 2023 |
| 18267992 | CD40 BINDING MOLECULES AND USES THEREOF | Tri-Institutional Therapeutics Discovery Institute, Inc. | HADDAD, MAHER M | 1641 | Non-Final OA | Jun 30, 2023 |
| 18138058 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Georgetown University | BARSKY, JARED | 1628 | Non-Final OA | Apr 22, 2023 |
| 18033249 | CD4+ TFH-LIKE CELLS AS A THERAPEUTIC TARGET | Cornell University | BENAVIDES, JENNIFER ANN | 1675 | Non-Final OA | Apr 21, 2023 |
| 18249248 | INDUCTION OF FERROPTOSIS FOR CANCER THERAPY | Memorial Sloan Kettering Cancer Center | HUDSON, AMY ROSE | 1636 | Non-Final OA | Apr 15, 2023 |
| 18041080 | CRYOPRESERVED ENDOTHELIAL CELL COMPOSITIONS | Angiocrine Bioscience, Inc. | ABBOTT, KODYE LEE | 1634 | Non-Final OA | Feb 09, 2023 |
| 17924982 | METHOD OF TREATMENT OF CANCER OR TUMOUR | USWM CT,LLC | AEDER, SEAN E | 1642 | Non-Final OA | Jan 23, 2023 |
| 18099486 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | Gomboc, LLC | RAMANA, ANURADHA | 3775 | Final Rejection | Jan 20, 2023 |
| 18003124 | ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED TOXICITY | Angiocrine Bioscience, Inc. | SCHUBERG, LAURA J | 1631 | Non-Final OA | Dec 22, 2022 |
| 18011171 | Administration of CEBP-Beta Antagonist and Methods of Use | Sapience Therapeutics, Inc. | STEELE, AMBER D | 1658 | Non-Final OA | Dec 17, 2022 |
| 18009320 | CHIMERIC ANTIGEN RECEPTOR CELL | UCL Business Ltd | HILL, KEVIN KAI | 1638 | Final Rejection | Dec 08, 2022 |
| 18050834 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF ADENO-ASSOCIATED VIRUS | Oxford Biomedica (Us) LLC | BURKHART, MICHAEL D | 1638 | Non-Final OA | Oct 28, 2022 |
| 17909427 | Replication Competent Virus Assay | Oxford Biomedica (Uk) Limited | WANG, RUIXUE | 1672 | Final Rejection | Sep 05, 2022 |
| 17821884 | ADENO-ASSOCIATED VIRUS FORMULATIONS | Oxford Biomedica (Us) LLC | GILL, RACHEL B | 1671 | Final Rejection | Aug 24, 2022 |
| 17724493 | PLANT-BASED BABY FOOD COMPOSITIONS | Nunona Inc. | NGUYEN, THANH H | 1792 | Non-Final OA | Apr 20, 2022 |
| 17614521 | COMPOSITIONS AND METHODS FOR THYMIC REGENERATION AND T-CELL RECONSTITUTION | Angiocrine Bioscience, Inc. | JOHNSON, ALLISON MARIE | 1638 | Final Rejection | Nov 27, 2021 |
| 17509910 | Methods of Safe Administration of Anti-Tau Antibody | Janssen Pharmaceutica NV | FONTAINHAS, AURORA M | 1675 | Final Rejection | Oct 25, 2021 |
| 17509889 | Methods of Reducing Tau in Human Subjects | Janssen Pharmaceutica NV | WANG, CHANG YU | 1675 | Non-Final OA | Oct 25, 2021 |
| 17476148 | PREDICTIVE BIOMARKERS FOR ADVERSE EFFECTS OF RADIATION THERAPY | Shuttle Pharmaceuticals Holdings, Inc. | LIMBAUGH, KATHRYN ELIZABETH | 1797 | Final Rejection | Sep 15, 2021 |
| 17435634 | CCR8 EXPRESSING LYMPHOCYTES FOR TARGETED TUMOR THERAPY | Klinikum Der Universitat Munchen | WESTON, ALYSSA G | 1633 | Non-Final OA | Sep 01, 2021 |
| 17196631 | METHODS AND COMPOSITIONS FOR DETECTION OF HPV DNA AND DIAGNOSIS AND MONITORING OF HPV-ASSOCIATED CANCERS | Memorial Sloan Kettering Cancer Center | HANEY, AMANDA MARIE | 1682 | Non-Final OA | Mar 09, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial